Sign In
Buy YI
$4.29
+0.590 (+15.95%)
At Close: Jun 23, 2026
111 to Announce Third Quarter 2022 Unaudited Financial Results on December 1, 2022 - Conference Call to Follow
01:09am, Tuesday, 08'th Nov 2022
SHANGHAI , Nov. 8, 2022 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and
111, Inc. (YI) Q2 2022 Earnings Call Transcript
01:01pm, Thursday, 25'th Aug 2022
111, Inc. (NASDAQ:YI ) Q2 2022 Earnings Conference Call August 25, 2022 7:30 AM ET Company Participants Monica Mu - Investor Relations Director Gang Yu - Co-Founder and Executive Chairman Junling Liu
111 to Announce Second Quarter 2022 Unaudited Financial Results on August 25, 2022 - Conference Call to Follow
02:26am, Friday, 05'th Aug 2022
SHANGHAI , Aug. 5, 2022 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and
111, Inc.'s Inexorable Drive Towards Profitability
11:36pm, Tuesday, 26'th Jul 2022
111, Inc. kept growing despite strong headwinds from pandemic lockdowns, which will continue to plague Q2 but not enough to lower FY22 outlook. 111, Inc. has plenty of growth avenues, particularly in
111 to Announce First Quarter 2022 Unaudited Financial Results on June 16, 2022 - Conference Call to Follow
04:59am, Thursday, 26'th May 2022
SHANGHAI, May 26, 2022 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and
111, Inc. (YI) CEO Junling Liu on Q4 2021 Results - Earnings Call Transcript
05:09pm, Thursday, 17'th Mar 2022
111, Inc. (YI) CEO Junling Liu on Q4 2021 Results - Earnings Call Transcript
111, Beilin Pharmaceutical team up to explore digital marketing of Chinese patent drugs
10:21am, Friday, 04'th Mar 2022 Seeking Alpha
111 Inc. (YI) signed an agreement with Xi''an Beilin Pharmaceutical to explore the digital marketing of Chinese patent medicines.Under the agreement the two companies will use…
111 to Announce Fourth Quarter and Fiscal Year 2021 Unaudited Financial Results on March 17, 2022 - Conference Call to Follow
03:38am, Tuesday, 22'nd Feb 2022
SHANGHAI, Feb. 22, 2022 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine an
111, Inc. (YI) CEO Junling Liu on Q3 2021 Results - Earnings Call Transcript
12:05pm, Friday, 19'th Nov 2021
111, Inc. (YI) CEO Junling Liu on Q3 2021 Results - Earnings Call Transcript
Solid Earnings, Modest Buyback Fail to Boost Drug Seller 111 Inc.
12:00pm, Friday, 17'th Sep 2021
Key takeaways: 111's revenue grew 87% in second quarter, generally outpacing its peers, as it aims to more than double its fulfillment capacity this year
111, Inc. Announces Participation in the Cantor Virtual Global Healthcare Conference
07:00am, Friday, 17'th Sep 2021
SHANGHAI, Sept. 17, 2021 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine a
111, Inc. Announces $10 Million Share Repurchase Program
05:00am, Tuesday, 07'th Sep 2021
SHANGHAI, Sept. 7, 2021 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine an
111, Inc. (YI) CEO Junling Liu on Q2 2021 Results - Earnings Call Transcript
12:51pm, Friday, 27'th Aug 2021
111, Inc. (YI) CEO Junling Liu on Q2 2021 Results - Earnings Call Transcript
111, Inc. Announces Second Quarter 2021 Unaudited Financial Results
02:30am, Friday, 27'th Aug 2021
SHANGHAI, Aug. 27, 2021 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine an
This Is the Only Chinese Stock I Would Buy Right Now
06:31am, Friday, 20'th Aug 2021
A diamond in the rough is a pretty rare find, especially among Chinese stocks.
